Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
GlobeNewswire
Presentations highlight data supporting FILSPARI^® (sparsentan) as a foundational therapy over historical RASi standard of care..